Copyright © Histochemical Society, Inc. A more recent version of this article appeared on February 1, 2006. Originally published as JHC exPRESS on August 8, 2005. doi:10.1369/jhc.5A6626.2005
Aberrant Gata-3 Expression in Human Pancreatic Cancer
1 Department of General Surgery (AG,POB,ZD,NG,JK,MWB,HF), Institute of Immunology (POB,TG,SM) and Department of Pathology (FA), University of Heidelberg, Heidelberg, Germany
* To whom correspondence should be addressed. E-mail: helmut_friess{at}med.uni-heidelberg.de.
signaling pathway. To determine the role of Gata-3 in pancreatic cancer, pancreatic cancer samples were analyzed in comparison to normal pancreatic tissues. Furthermore, four different pancreatic cancer cell lines with different alterations of the TGF- pathway were studied. To evaluate if a potential relationship with TGF- signaling pathway exists, we correlated mRNA expression levels with the expression of TGF- s, TGF- receptors and smad-3. Finally, we analyzed the influence of TGF- on Gata-3 expression in vitro. All pancreatic cancer samples demonstrated a marked overexpression of Gata-3 mRNA and protein. Immunohistochemical staining revealed strong and persistent cytoplasmatic Gata-3 immunoreactivity in cancer cells. In an electrophoretic mobility shift assay, a disturbed nuclear translocation was confirmed. The expression of Gata-3 showed a significant correlation with the expression of TGF- s, TGF- receptors and Smad-3. TGF- responsive cell lines showed a down-regulation of Gata-3 mRNA upon TGF- exposure, whereas in TGF- unresponsive cell lines, Gata-3 mRNA expression persisted on high levels. Furthermore, strong specific up-regulation of Gata-3, impaired nuclear translocation and its cooperative action with the TGF- pathway, suggesting that Gata-3 plays a central role in human pancreatic cancer.
Key Words:
Gata-3, TGF-
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||